Bioavailability is usually determined by calculating the respective plasma drug exposure assessed as the total area under the drug plasma concentration versus time curve (AUC) after oral and intravenous administration as: In general, determinants of oral drug bioavailability include fraction of dose absorbed in the gastrointestinal tract (GIT) and fraction of dose that escapes elimination by the intestinal tract, liver, and lung
The specific reasons identified include intensive insulin therapy, decreased renal function, severe liver disease, alcohol ingestion, defective counter regulatory hormone release, missing meals/fasting, and gastroparesis
Hold the dose steady for 2 weeks before adjusting
In contrast, the use of oils rich in n-3 polyunsaturated fatty acids attenuate the process
Our signature IV infusions deliver hydration, vitamins, and nutrients directly to your bloodstream for 100% absorption